Doença de Huntington

Professor of Clinical Neurology

Honorary Consultant Neurologist

UCL Institute of Neurology

London

UK

Declarações

SJT receives grant funding for her research from CHDI Foundation, the BBSRC, Dementia and Neurodegenerative Disease Network UK, European Huntington’s Disease Network, Huntington’s Disease Association of the UK, the Medical Research Council UK, Takeda Pharmaceuticals, the UCL/UCLH Biomedical Research Centre, and the Wellcome Trust. In the past year, SJT has been on advisory boards or had consultancies with F. Hoffmann-La Roche Ltd, Ixico Technologies, Shire Human Genetic Therapies, Takeda Pharmaceuticals International, and TEVA Pharmaceuticals. All honoraria for these consultancies and advisory boards were paid to UCL. Through the offices of UCL Consultants Ltd, a wholly owned subsidiary of University College London, SJT has undertaken consultancy services for F. Hoffmann-La Roche Ltd and GSK. ST is also an author of references cited in this topic.

Wellcome Trust Clinical Research Fellow

UCL Institute of Neurology

London

UK

Declarações

PM declares that he has no competing interests.

Senior Lecturer in Neuropsychiatric Genetics

University of Manchester

Manchester Academic Health Sciences Centre and Central Manchester University Hospitals NHS Foundation Trust

St Mary's Hospital

Manchester

UK

Declarações

DC has received fees for advisory board membership from Hoffmann-La Roche Ltd.

Dr Sarah Tabrizi, Dr Peter McColgan, and Dr David Craufurd would like to gratefully acknowledge Dr Marianne Novak and Dr Francis Walker, previous contributors to this monograph. FW declares that he has no competing interests. MN is author of a reference cited in this monograph.